secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2022-05-13T23:59:59+00:00
Accession:  0001683168-22-003584
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNBX Pharma effects 1:120 reverse split and cuts authorized preferred to 5M shares
--------------------------------------------------------------------------------

- Reverse stock split of 1:120 effective May 12, 2022; par value unchanged.
- Authorized preferred shares reduced from 100,000,000 to 5,000,000.
- Common stock now trades on OTCQB under new symbol CNBXD; new CUSIP 13764M209.
- The reverse split was effected by filing a Certificate of Change with Nevada Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316822003584/0001683168-22-003584-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316822003584/cnbx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-003584

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer